1. Cost and Clinical Analysis of Autologous Hematopoietic Stem Cell Mobilization with G- CSF and Plerixafor Compared to G-CSF and Cyclophosphamide 
Paul Shaughnessy, Miguel Islas-Ohlmayer, Julie Murphy, Maureen Hougham, Jill MacPherson, Kurt Winkler, Matthew Silva, Michael Steinberg, Jeffrey Matous, Sheryl Selvey, Michael Maris, Peter A. McSweeney 
Biology of Blood and Marrow Transplantation 
Volume 17, Issue 5, Pages (May 2011)
DOI: /j.bbmt
Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1 Chemotherapy mobilization dosing regimen (control patients).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2 Perixafor mobilization dosing regimen (EAP study patients).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Total median costs associated with successive days to mobilization. The total cost of mobilization for each patient was determined through the indicated day of apheresis and medians were calcultaed for each group in each day of apheresis. The upper boundary of the box represents the 75th percentile and the lower boundary the 25th percentile; the line represents the median for each group.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions